Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...
Main Authors: | Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2019
|
Similar Items
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
by: Wang, Y, et al.
Published: (2020) -
Does Oseltamivir Really Reduce Complications of Influenza?
by: Del Mar, C, et al.
Published: (2011) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
by: Chairat, K, et al.
Published: (2016) -
Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
by: Lee, J, et al.
Published: (2020) -
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
by: Butler, CC, et al.
Published: (2019)